Mary Szela is the Chief Executive Officer, President, and Director of TriSalus Life Sciences, a role she has held since January 2018.
Mary Szela is the Chief Executive Officer, President, and Director of TriSalus Life Sciences, a role she has held since January 2018. She possesses nearly 35 years of experience in both commercial and clinical pharmaceutical sectors. Prior to TriSalus, she served as CEO of Novelion Therapeutics and Melinta Therapeutics, and held leadership roles at Abbott Laboratories, including President of its U.S. pharmaceutical business.
Full founder directory · Investor directory · Company funding database · Fundraising library